The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction, and their partners

被引：0
|
作者：
Subramonian, K [1 ]
Weston, PMT [1 ]
机构：
[1] Pinderfields Hosp, Wakefield, England
来源：
BJU INTERNATIONAL | 1999年 / 83卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1087 / 1087
页数：1
相关论文
共 50 条
  • [1] The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction, and their partners
    Williams, G
    Abbou, CC
    Amar, ET
    Desvaux, P
    Flam, TA
    Nijeholt, GABLA
    Lynch, SF
    Morgan, RJ
    Müller, SC
    Porst, H
    Pryor, JP
    Ryan, P
    Witzsch, UKF
    Hall, MM
    Place, VA
    Spivack, AP
    Todd, LK
    Gesundheit, N
    [J]. BRITISH JOURNAL OF UROLOGY, 1998, 82 (06): : 847 - 854
  • [2] Treatment of men with erectile dysfunction with transurethral alprostadil
    PadmaNathan, H
    Hellstrom, WJG
    Kaiser, FE
    Labasky, RF
    Lue, TF
    Nolten, WE
    Norwood, PC
    Peterson, CA
    Shabsigh, R
    Tam, PY
    Place, VA
    Gesundheit, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (01): : 1 - 7
  • [3] Treatment of erectile dysfunction with transurethral alprostadil: Effects on quality of life
    Kaiser, FE
    Weldon, K
    Gesundheit, N
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (09) : A33 - A33
  • [4] Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction
    Williams, G
    Abbou, CC
    Amar, ET
    Desvaux, P
    Flam, TA
    Lycklama a Nijeholt, GAB
    Lynch, SF
    Morgan, RJ
    Müller, SC
    Porst, H
    Pryor, JP
    Ryan, P
    Witzsch, UKF
    Hall, MM
    Place, VA
    Spivack, AP
    Gesundheit, N
    [J]. BRITISH JOURNAL OF UROLOGY, 1998, 81 (06): : 889 - 894
  • [5] Thalassaemic men affected by erectile dysfunction treated with transurethral alprostadil
    Lombardo, T
    Giammusso, B
    Frontini, V
    D'Arpa, S
    Pafumi, C
    Caruso, S
    [J]. HUMAN REPRODUCTION, 2000, 15 (11) : 2375 - 2378
  • [6] Quality of life in diabetic men with erectile dysfunction: Sildenafil versus alprostadil
    Gentile, S
    Turco, S
    Guarino, G
    Corigliano, G
    Sasso, FC
    Turco, AA
    Agrusta, M
    Armentano, V
    [J]. DIABETES, 2000, 49 : A108 - A108
  • [7] Transurethral alprostadil for the treatment of erectile dysfunction in men with diabetes: Effect of duration of diabetes on efficacy.
    Kaiser, FE
    Block, MB
    Bookin, S
    Decherney, GS
    Hershon, KS
    Nolten, WE
    Norwood, PC
    Rosenblatt, S
    Rosenstock, J
    Schalch, DS
    Schwartz, SL
    Stephens, D
    Tam, PY
    Todd, LK
    Gesundheit, N
    [J]. DIABETES, 1997, 46 : 637 - 637
  • [8] Treatment of chronic erectile dysfunction with transurethral alprostadil in diabetic and nondiabetic men.
    Norwood, PC
    Kaiser, FE
    Nolten, WE
    Schalch, DS
    Place, VA
    Spivack, AP
    Stephens, DE
    Tam, PY
    Gesundheit, N
    [J]. DIABETOLOGIA, 1997, 40 : 2324 - 2324
  • [9] Efficacy of transurethral alprostadil (MUSE®) vs. transurethral alprostadil/prazosin (ALIBRA™) in men with complete, organic erectile dysfunction.
    Costabile, RA
    [J]. JOURNAL OF UROLOGY, 1998, 159 (05): : 237 - 237
  • [10] Quality of life effects of alprostadil therapy for erectile dysfunction
    Willke, RJ
    Glick, HA
    McCarron, TJ
    Erder, MH
    Althof, SE
    Linet, OI
    [J]. JOURNAL OF UROLOGY, 1997, 157 (06): : 2124 - 2128
12345